OutlookTherapeutics OTLK full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Outlook Therapeutics OTLK WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange
operates under Health Care sector & deals in Biotechnology Biological Products No Diagnostic Substances
Daily price and charts and targets OutlookTherapeutics
Strong Daily Stock price targets for OutlookTherapeutics OTLK are 1.7 and 1.92
| Daily Target 1 | 1.52 |
| Daily Target 2 | 1.66 |
| Daily Target 3 | 1.74 |
| Daily Target 4 | 1.88 |
| Daily Target 5 | 1.96 |
Daily price and volume Outlook Therapeutics
| Date | Closing | Open | Range | Volume | Thu 29 May 2025 | 1.80 (10.43%) | 1.66 | 1.60 - 1.82 | 1.6831 times | Wed 28 May 2025 | 1.63 (1.24%) | 1.61 | 1.55 - 1.63 | 0.2658 times | Tue 27 May 2025 | 1.61 (0.63%) | 1.65 | 1.57 - 1.70 | 0.9421 times | Fri 23 May 2025 | 1.60 (-2.44%) | 1.55 | 1.47 - 1.73 | 2.297 times | Thu 22 May 2025 | 1.64 (0.61%) | 1.60 | 1.55 - 1.67 | 1.0728 times | Wed 21 May 2025 | 1.63 (-4.12%) | 1.67 | 1.59 - 1.73 | 1.0991 times | Tue 20 May 2025 | 1.70 (0%) | 1.74 | 1.66 - 1.78 | 0.7387 times | Tue 20 May 2025 | 1.70 (-3.41%) | 1.74 | 1.66 - 1.78 | 0.7387 times | Mon 19 May 2025 | 1.76 (0.57%) | 1.73 | 1.67 - 1.77 | 0.7668 times | Fri 16 May 2025 | 1.75 (4.17%) | 1.70 | 1.65 - 1.80 | 0.3959 times | Thu 15 May 2025 | 1.68 (-4%) | 1.74 | 1.62 - 1.79 | 0.3768 times |
Weekly price and charts OutlookTherapeutics
Strong weekly Stock price targets for OutlookTherapeutics OTLK are 1.68 and 1.95
| Weekly Target 1 | 1.45 |
| Weekly Target 2 | 1.63 |
| Weekly Target 3 | 1.7233333333333 |
| Weekly Target 4 | 1.9 |
| Weekly Target 5 | 1.99 |
Weekly price and volumes for Outlook Therapeutics
| Date | Closing | Open | Range | Volume | Thu 29 May 2025 | 1.80 (12.5%) | 1.65 | 1.55 - 1.82 | 1.5026 times | Fri 23 May 2025 | 1.60 (-5.88%) | 1.74 | 1.47 - 1.78 | 2.7067 times | Tue 20 May 2025 | 1.70 (-2.86%) | 1.73 | 1.66 - 1.78 | 0.7825 times | Fri 16 May 2025 | 1.75 (14.38%) | 1.55 | 1.53 - 2.04 | 2.6242 times | Fri 09 May 2025 | 1.53 (-1.29%) | 1.56 | 1.35 - 1.60 | 0.7769 times | Fri 02 May 2025 | 1.55 (1.31%) | 1.53 | 1.45 - 1.62 | 0.8254 times | Fri 25 April 2025 | 1.53 (5.52%) | 1.45 | 1.40 - 1.58 | 0.4191 times | Thu 17 April 2025 | 1.45 (5.84%) | 1.36 | 1.32 - 1.49 | 0.1914 times | Wed 16 April 2025 | 1.37 (0%) | 1.36 | 1.33 - 1.41 | 0.1711 times | Wed 16 April 2025 | 1.37 (0%) | 1.36 | 1.32 - 1.41 | 0 times | Wed 16 April 2025 | 1.37 (0%) | 1.36 | 1.32 - 1.41 | 0 times |
Monthly price and charts OutlookTherapeutics
Strong monthly Stock price targets for OutlookTherapeutics OTLK are 1.58 and 2.27
| Monthly Target 1 | 1.04 |
| Monthly Target 2 | 1.42 |
| Monthly Target 3 | 1.73 |
| Monthly Target 4 | 2.11 |
| Monthly Target 5 | 2.42 |
Monthly price and volumes Outlook Therapeutics
| Date | Closing | Open | Range | Volume | Thu 29 May 2025 | 1.80 (14.65%) | 1.57 | 1.35 - 2.04 | 1.3185 times | Wed 30 April 2025 | 1.57 (28.69%) | 1.21 | 1.06 - 1.61 | 0.6994 times | Mon 31 March 2025 | 1.22 (-18.67%) | 1.56 | 1.19 - 1.57 | 0.721 times | Fri 28 February 2025 | 1.50 (-27.18%) | 1.97 | 1.32 - 1.99 | 1.215 times | Fri 31 January 2025 | 2.06 (8.99%) | 1.90 | 1.80 - 2.60 | 2.141 times | Tue 31 December 2024 | 1.89 (-61.35%) | 1.53 | 1.26 - 2.18 | 1.7961 times | Tue 26 November 2024 | 4.89 (-15.1%) | 5.82 | 4.84 - 6.98 | 0.5454 times | Thu 31 October 2024 | 5.76 (7.87%) | 5.47 | 4.61 - 5.94 | 0.5969 times | Mon 30 September 2024 | 5.34 (-27.35%) | 7.28 | 5.22 - 8.32 | 0.6415 times | Fri 30 August 2024 | 7.35 (-5.16%) | 7.75 | 6.90 - 8.09 | 0.3252 times | Wed 31 July 2024 | 7.75 (5.01%) | 7.37 | 6.93 - 9.25 | 0.4334 times |
Indicator Analysis of OutlookTherapeutics
Tomorrow's movement Prediction of Outlook Therapeutics OTLK appears to be in uptrend. And this trend seems to be continuing further.
Price is above an important level of 1.66 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Outlook Therapeutics OTLK made a big move recently. This generally happens when there is a positive sentiment change, or a block deal went through. There is a good chance that this trend might continue in coming days.
Tomorrow's movement Prediction of Outlook Therapeutics OTLK appears strongly Bullish. This stock started moving upwards as soon as it opened. Generally this happens when there is a positive sentiment following the stock, making it attractive. There's a good chance that this upwards movement will continue tomorrow as well.
Tomorrow's movement Prediction of Outlook Therapeutics OTLK is bullish. The stock is trading above weekly resistance and downside can only be expected once it trades below 1.69
Munafa value: 100 as on Thu 29 May 2025
If this Munafa value is near or nearing 100, then this stock might show an upward movement. However, if this value is near or nearing 10, then this stock might very well show a downward movement.
If the Munafa value is near 50, then the stock might show a sideways movement.
SMA20 is at 2 and price is deviating by 1 points
Upper Bollinger band is at 2 and lower is at 2, while middle bands are at 2 and 2
Price is rising
Price is above 20day SMA
Price is in upper range of bands
Price action analysis of OutlookTherapeutics (OTLK) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for OutlookTherapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for OutlookTherapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
OutlookTherapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for OutlookTherapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of OutlookTherapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.68 and OutlookTherapeutics OTLK stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the OutlookTherapeutics OTLK stock. Volume based technical analysis of OutlookTherapeutics OTLK stock is negative.
OutlookTherapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Outlook Therapeutics OTLK
DMA (daily moving average) of Outlook Therapeutics OTLK
| DMA period | DMA value |
| 5 day DMA | 1.66 |
| 12 day DMA | 1.69 |
| 20 day DMA | 1.64 |
| 35 day DMA | 1.56 |
| 50 day DMA | 1.48 |
| 100 day DMA | 1.57 |
| 150 day DMA | 2.21 |
| 200 day DMA | 3.19 |
EMA (exponential moving average) of Outlook Therapeutics OTLK
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 1.69 | 1.64 | 1.64 |
| 12 day EMA | 1.66 | 1.64 | 1.64 |
| 20 day EMA | 1.64 | 1.62 | 1.62 |
| 35 day EMA | 1.56 | 1.55 | 1.55 |
| 50 day EMA | 1.49 | 1.48 | 1.47 |
SMA (simple moving average) of Outlook Therapeutics OTLK
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 1.66 | 1.62 | 1.64 |
| 12 day SMA | 1.69 | 1.71 | 1.7 |
| 20 day SMA | 1.64 | 1.63 | 1.62 |
| 35 day SMA | 1.56 | 1.55 | 1.54 |
| 50 day SMA | 1.48 | 1.47 | 1.46 |
| 100 day SMA | 1.57 | 1.57 | 1.58 |
| 150 day SMA | 2.21 | 2.23 | 2.26 |
| 200 day SMA | 3.19 | 3.22 | 3.25 |
Terms of Use Stock Market News! © munafasutra.org2025 All Rights reserved.